rOPCML protein therapy (Cancer Research UK)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamerOPCML protein therapy (Cancer Research UK)
Drug Alias Namerecombinant opioid binding protein cell adhesion molecule protein therapy (Cancer Research UK)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionProtein-tyrosine kinases inhibitors
TargetsProtein-tyrosine kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research TechnologyCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A